1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19

6. Inhalation & Nasal Sprays Generic Drugs Market, by Indication
6.1. Introduction
6.2. Allergic Rhinitis
6.3. Asthma
6.4. COPD

7. Inhalation & Nasal Sprays Generic Drugs Market, by Age Group
7.1. Introduction
7.2. Adults
7.3. Children 2 to 5
7.4. Children 6 to 12

8. Inhalation & Nasal Sprays Generic Drugs Market, by Class
8.1. Introduction
8.2. Allergy Blocker
8.3. Anticholinergic
8.4. Antihistamine
8.5. Decongestant
8.6. Mast Cell Inhibitor
8.7. Nasal Steroid

9. Inhalation & Nasal Sprays Generic Drugs Market, by Route
9.1. Introduction
9.2. Inhalation
9.3. Nasal Spray
9.4. Tropical Lotion

10. Inhalation & Nasal Sprays Generic Drugs Market, by Distrubution Channel
10.1. Introduction
10.2. Hospital Medical Store
10.3. Online Pharmacy
10.4. Pharmacy Retail

11. California Inhalation & Nasal Sprays Generic Drugs Market

12. Florida Inhalation & Nasal Sprays Generic Drugs Market

13. Illinois Inhalation & Nasal Sprays Generic Drugs Market

14. New York Inhalation & Nasal Sprays Generic Drugs Market

15. Ohio Inhalation & Nasal Sprays Generic Drugs Market

16. Pennsylvania Inhalation & Nasal Sprays Generic Drugs Market

17. Texas Inhalation & Nasal Sprays Generic Drugs Market

18. Competitive Landscape
18.1. FPNV Positioning Matrix
18.1.1. Quadrants
18.1.2. Business Strategy
18.1.3. Product Satisfaction
18.2. Market Ranking Analysis
18.3. Market Share Analysis, By Key Player
18.4. Competitive Scenario
18.4.1. Merger & Acquisition
18.4.2. Agreement, Collaboration, & Partnership
18.4.3. New Product Launch & Enhancement
18.4.4. Investment & Funding
18.4.5. Award, Recognition, & Expansion

19. Company Usability Profiles
19.1. Allergan plc
19.2. Altaire Pharmaceuticals Inc.
19.3. Beximco Pharmaceuticals Ltd
19.4. Catalent Pharma Solutions
19.5. Cipla Limited
19.6. Hikma Pharmaceuticals PLC
19.7. Mylan N.V.
19.8. Navajo Manufacturing Company Inc.
19.9. Nephron Pharmaceuticals Corporation
19.10. Perrigo Company plc
19.11. Preferred Pharmaceuticals Inc.
19.12. Sandoz International GmbH
19.13. Sheffield Pharmaceuticals LLC
19.14. Sun Pharmaceutical Industries Ltd.
19.15. Teva Pharmaceutical Industries Ltd.

20. Appendix
20.1. Discussion Guide
20.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET: MARKET DYNAMICS
FIGURE 3. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2020 VS 2027 (%)
FIGURE 4. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2020 VS 2027 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2027
FIGURE 6. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, 2018-2027 (USD MILLION)
FIGURE 7. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 8. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ASTHMA, 2018-2027 (USD MILLION)
FIGURE 9. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ASTHMA, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 10. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY COPD, 2018-2027 (USD MILLION)
FIGURE 11. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY COPD, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 12. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2020 VS 2027 (%)
FIGURE 13. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2020 VS 2027 (USD MILLION)
FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2027
FIGURE 15. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ADULTS, 2018-2027 (USD MILLION)
FIGURE 16. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ADULTS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 17. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CHILDREN 2 TO 5, 2018-2027 (USD MILLION)
FIGURE 18. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CHILDREN 2 TO 5, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 19. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CHILDREN 6 TO 12, 2018-2027 (USD MILLION)
FIGURE 20. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CHILDREN 6 TO 12, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 21. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2020 VS 2027 (%)
FIGURE 22. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2020 VS 2027 (USD MILLION)
FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2027
FIGURE 24. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ALLERGY BLOCKER, 2018-2027 (USD MILLION)
FIGURE 25. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ALLERGY BLOCKER, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 26. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ANTICHOLINERGIC, 2018-2027 (USD MILLION)
FIGURE 27. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ANTICHOLINERGIC, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 28. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ANTIHISTAMINE, 2018-2027 (USD MILLION)
FIGURE 29. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ANTIHISTAMINE, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 30. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DECONGESTANT, 2018-2027 (USD MILLION)
FIGURE 31. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DECONGESTANT, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 32. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY MAST CELL INHIBITOR, 2018-2027 (USD MILLION)
FIGURE 33. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY MAST CELL INHIBITOR, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 34. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NASAL STEROID, 2018-2027 (USD MILLION)
FIGURE 35. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NASAL STEROID, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 36. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2020 VS 2027 (%)
FIGURE 37. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2020 VS 2027 (USD MILLION)
FIGURE 38. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2027
FIGURE 39. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2018-2027 (USD MILLION)
FIGURE 40. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 41. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NASAL SPRAY, 2018-2027 (USD MILLION)
FIGURE 42. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NASAL SPRAY, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 43. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY TROPICAL LOTION, 2018-2027 (USD MILLION)
FIGURE 44. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY TROPICAL LOTION, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 45. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2020 VS 2027 (%)
FIGURE 46. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2020 VS 2027 (USD MILLION)
FIGURE 47. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2027
FIGURE 48. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY HOSPITAL MEDICAL STORE, 2018-2027 (USD MILLION)
FIGURE 49. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY HOSPITAL MEDICAL STORE, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 50. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2027 (USD MILLION)
FIGURE 51. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 52. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PHARMACY RETAIL, 2018-2027 (USD MILLION)
FIGURE 53. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PHARMACY RETAIL, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 54. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET: FPNV POSITIONING MATRIX
FIGURE 55. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 56. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET, BY TYPE

List of Tables

TABLE 1. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 4. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, BY STATE, 2018-2027 (USD MILLION)
TABLE 5. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ASTHMA, BY STATE, 2018-2027 (USD MILLION)
TABLE 6. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY COPD, BY STATE, 2018-2027 (USD MILLION)
TABLE 7. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2018-2027 (USD MILLION)
TABLE 8. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ADULTS, BY STATE, 2018-2027 (USD MILLION)
TABLE 9. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CHILDREN 2 TO 5, BY STATE, 2018-2027 (USD MILLION)
TABLE 10. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CHILDREN 6 TO 12, BY STATE, 2018-2027 (USD MILLION)
TABLE 11. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2018-2027 (USD MILLION)
TABLE 12. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ALLERGY BLOCKER, BY STATE, 2018-2027 (USD MILLION)
TABLE 13. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ANTICHOLINERGIC, BY STATE, 2018-2027 (USD MILLION)
TABLE 14. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ANTIHISTAMINE, BY STATE, 2018-2027 (USD MILLION)
TABLE 15. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DECONGESTANT, BY STATE, 2018-2027 (USD MILLION)
TABLE 16. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY MAST CELL INHIBITOR, BY STATE, 2018-2027 (USD MILLION)
TABLE 17. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NASAL STEROID, BY STATE, 2018-2027 (USD MILLION)
TABLE 18. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2018-2027 (USD MILLION)
TABLE 19. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, BY STATE, 2018-2027 (USD MILLION)
TABLE 20. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NASAL SPRAY, BY STATE, 2018-2027 (USD MILLION)
TABLE 21. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY TROPICAL LOTION, BY STATE, 2018-2027 (USD MILLION)
TABLE 22. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 23. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY HOSPITAL MEDICAL STORE, BY STATE, 2018-2027 (USD MILLION)
TABLE 24. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY STATE, 2018-2027 (USD MILLION)
TABLE 25. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PHARMACY RETAIL, BY STATE, 2018-2027 (USD MILLION)
TABLE 26. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET: SCORES
TABLE 27. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET: BUSINESS STRATEGY
TABLE 28. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET: PRODUCT SATISFACTION
TABLE 29. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET: RANKING
TABLE 30. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 31. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET: MERGER & ACQUISITION
TABLE 32. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 33. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 34. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET: INVESTMENT & FUNDING
TABLE 35. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 36. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET: LICENSE & PRICING

Companies Mentioned

Allergan plc
Altaire Pharmaceuticals Inc.
Beximco Pharmaceuticals Ltd
Catalent Pharma Solutions
Cipla Limited
Hikma Pharmaceuticals PLC
Mylan N.V.
Navajo Manufacturing Company Inc.
Nephron Pharmaceuticals Corporation
Perrigo Company plc
Preferred Pharmaceuticals Inc.
Sandoz International GmbH
Sheffield Pharmaceuticals LLC
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.